KAS
FTXH icon

Kestra Advisory Services’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Kestra Advisory Services’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,789
Closed -$58.9K – 3589
2025
Q4 		$58.9K Buy
+1,789
New +$55.7K ﹤0.01% 3831

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Kestra Advisory Services's FTXH Position: Q1 2026 in Review

Kestra Advisory Services sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2026, closing a stake of 1,789 shares — an estimated $58.9K sold.

Kestra Advisory Services first reported a position in FTXH in Q4 2025 and held it in 1 quarter. The position peaked at $58.9K in Q4 2025. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

  • Kestra Advisory Services reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 1,789 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2026, an estimated $58.9K.
  • Kestra Advisory Services first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2025 and held it in 1 quarter.
  • Kestra Advisory Services's First Trust Nasdaq Pharmaceuticals ETF position peaked at $58.9K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.